How Gilead Monetized The Pandemic

July 12, 2020

You’d think any drug developed to help fight the pandemic would be affordable, right? Nope. Here’s how Gilead plans to make billions in profits off human suffering.

Gilead Sciences, Inc. /ˈɡɪliəd/, is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIVhepatitis Bhepatitis C, and influenza, including Harvoni and Sovaldi.

Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.



Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: